The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target

Title
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target
Authors
Keywords
Angiogenesis; novel target; pyrazolyl-urea; kinase inhibitors; DMPK
Journal
Oncotarget
Volume 8, Issue 64, Pages -
Publisher
Impact Journals, LLC
Online
2017-11-22
DOI
10.18632/oncotarget.22598

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now